Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1996-12-11
|
pubmed:abstractText |
Little is known about the outcome of multidrug resistant (MDR) tuberculosis (TB) in developing countries. In this study, 443 patients with MDR-TB, defined as resistance to two or more antituberculosis drugs, were identified over the 2-year period 1987 and 1988 in the Cape Province of South Africa. The 5-year outcome of the 343 (77%) patients that could be traced by questionnaire was evaluated retrospectively during 1992 and 1993. Of these, 240 (70%) were resistant to both isoniazid (H) and rifampicin (R) with or without resistance to other first-line antituberculosis drugs and 103 (30%) were resistant to H or R and/or other antituberculosis drugs. Mortality was 116 (48%) and 28 (27%) in these groups respectively with a significantly greater risk of death in the first group. Only 114 (33%) of all the MDR-TB patients were cured after 5 years, 50 (15%) were respiratory disabled and 44 (13%) were still bacteriology positive. Twenty-four (7%) patients were lost during follow-up. Taking into account the high costs involved in treating MDR-TB patients and the scarce resources available in developing countries, more emphasis should be placed on direct observed therapy to cure newly diagnosed infectious drug sensitive tuberculosis patients, thus preventing MDR-TB rather than treating it.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1360-2276
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
1
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
718-22
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8911459-Adolescent,
pubmed-meshheading:8911459-Adult,
pubmed-meshheading:8911459-Aged,
pubmed-meshheading:8911459-Antitubercular Agents,
pubmed-meshheading:8911459-Female,
pubmed-meshheading:8911459-Humans,
pubmed-meshheading:8911459-Isoniazid,
pubmed-meshheading:8911459-Male,
pubmed-meshheading:8911459-Middle Aged,
pubmed-meshheading:8911459-Mycobacterium tuberculosis,
pubmed-meshheading:8911459-Outcome Assessment (Health Care),
pubmed-meshheading:8911459-Pyrazinamide,
pubmed-meshheading:8911459-Questionnaires,
pubmed-meshheading:8911459-Retrospective Studies,
pubmed-meshheading:8911459-Rifampin,
pubmed-meshheading:8911459-South Africa,
pubmed-meshheading:8911459-Time Factors,
pubmed-meshheading:8911459-Tuberculosis, Multidrug-Resistant
|
pubmed:year |
1996
|
pubmed:articleTitle |
The 5-year outcome of multidrug resistant tuberculosis patients in the Cape Province of South Africa.
|
pubmed:affiliation |
Department of Paediatrics and Child Health, Tygerberg Hospital, South Africa.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|